What is the current Price Target for the Altimmune, Inc. stock?

The average Altimmune, Inc. target price is $18.36. This is 565.22% higher than the current stock price. The highest price target is 965.22%, the lowest is 302.54%. 10 Analysts have issued a price target Altimmune, Inc. 2027 .

How high will the Altimmune, Inc. stock rise?

No reliable answer can be given as to how high the Altimmune, Inc. stock will rise. The performance of stocks, including the Altimmune, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Altimmune, Inc. stock today?

The performance of Altimmune, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Altimmune, Inc. stock fall?

The decline in Altimmune, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Altimmune, Inc. Forecast, price target & analysts

$2.76

3.50%

Nasdaq, Oct 01, 04:10 pm EDT. Closed.

ISIN

US02155H1014

Symbol

ALT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Ownership News Strategies

Altimmune, Inc. Target price 2026 - Analyst rating & recommendation

Altimmune, Inc. Classifications & Recommendation

Buy

87%

Hold

13%

Altimmune, Inc. Price Target

Target Price	$18.36
Price	$2.76
Potential	565.22% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target Altimmune, Inc. 2027 . The average Altimmune, Inc. target price is $18.36. This is 565.22% register free of charge higher than the current stock price. The highest price target is $29.40 965.22% register free of charge , the lowest is $11.11 302.54% register free of charge .
	A rating was issued by 15 analysts: 13 Analysts recommend Altimmune, Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Altimmune, Inc. stock has an average upside potential 2027 of 565.22% register free of charge . Most analysts recommend the Altimmune, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.00	-0.59
	25.37%	41.00%
P/E		negative

11 Analysts have issued a Altimmune, Inc. forecast for earnings per share. The average Altimmune, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.00	25.37%
2026	$-0.59 41.00% unlock
2027	$-0.65 10.17% unlock
2028	$-0.76 16.92% unlock
2029	$-1.03 35.53% unlock
2030	$-0.77 25.24% unlock
2031	$0.41 153.25% unlock
2032	$1.09 165.85% unlock
2033	$2.04 87.16% unlock

Current	-5.63	50.68%
2026	-4.66 17.27% unlock
2027	-4.26 8.58% unlock
2028	-3.64 14.55% unlock
2029	-2.69 26.10% unlock
2030	-3.58 33.09% unlock
2031	6.75 288.55% unlock
2032	2.53 62.52% unlock
2033	1.35 46.64% unlock

Altimmune, Inc....

Current Altimmune, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Evercore ISI Group	Locked ➜ Locked	Locked	Sep 23 2026
Leerink Partners	Locked ➜ Locked	Locked	Jun 22 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 18 2026
Citizens	Locked ➜ Locked	Locked	May 14 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 16 2026
B. Riley Securities	Locked ➜ Locked	Locked	Mar 06 2026
Citizens	Locked ➜ Locked	Locked	Nov 07 2025

Analyst Rating	Date
Locked Evercore ISI Group: Locked ➜ Locked	Sep 23 2026
Locked Leerink Partners: Locked ➜ Locked	Jun 22 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 18 2026
Locked Citizens: Locked ➜ Locked	May 14 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 16 2026
Locked B. Riley Securities: Locked ➜ Locked	Mar 06 2026
Locked Citizens: Locked ➜ Locked	Nov 07 2025

Discover more stocks with a high price target

NIO ADR 85.25%

Alibaba Group Holding Ltd 78.14%

Rheinmetall 72.55%

Tencent Holdings Ltd. 57.61%

Adyen 57.36%

Infineon 55.35%

Uber Technologies 51.77%

BYD 46.92%

Siemens Energy 46.72%

TUI 45.17%

Adidas 43.01%

Netflix 42.06%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now